MA41826B1 - Anticorps anti-icos - Google Patents

Anticorps anti-icos

Info

Publication number
MA41826B1
MA41826B1 MA41826A MA41826A MA41826B1 MA 41826 B1 MA41826 B1 MA 41826B1 MA 41826 A MA41826 A MA 41826A MA 41826 A MA41826 A MA 41826A MA 41826 B1 MA41826 B1 MA 41826B1
Authority
MA
Morocco
Prior art keywords
antibodies
icos antibodies
icos
bind
cancer
Prior art date
Application number
MA41826A
Other languages
English (en)
Inventor
Stephen Sazinsky
Jennifer S Michaelson
Sriram Sathyanarayanan
Kutlu Goksu Elpek
Original Assignee
Jounce Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jounce Therapeutics Inc filed Critical Jounce Therapeutics Inc
Priority claimed from PCT/US2016/023524 external-priority patent/WO2016154177A2/fr
Publication of MA41826B1 publication Critical patent/MA41826B1/fr

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne divers modes de réalisation se rapportant à des anticorps. Certains des modes de réalisation concernent des anticorps agonistes qui se lient à icos. Ces anticorps peuvent être utilisés dans des méthodes pour traiter, par exemple, le cancer.
MA41826A 2015-03-23 2016-03-22 Anticorps anti-icos MA41826B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562137034P 2015-03-23 2015-03-23
PCT/US2016/023524 WO2016154177A2 (fr) 2015-03-23 2016-03-22 Anticorps anti-icos

Publications (1)

Publication Number Publication Date
MA41826B1 true MA41826B1 (fr) 2020-08-31

Family

ID=59256490

Family Applications (1)

Application Number Title Priority Date Filing Date
MA41826A MA41826B1 (fr) 2015-03-23 2016-03-22 Anticorps anti-icos

Country Status (2)

Country Link
AR (1) AR104041A1 (fr)
MA (1) MA41826B1 (fr)

Also Published As

Publication number Publication date
AR104041A1 (es) 2017-06-21

Similar Documents

Publication Publication Date Title
MA46708B1 (fr) Anticorps anti-pd1 et leurs utilisations
MY191169A (en) Anti-fcrh5 antibodies
EA201990615A1 (ru) Пирролобензодиазепиновые конъюгаты
MA39313A1 (fr) Anticorps anti-egfrviii et leurs utilisations dans le traitement de divers cancers
MA40576B1 (fr) Anticorps et immunoconjugués anti-her2
CL2018003758A1 (es) Conjugados anticuerpo anti-dll3-fármaco y métodos de uso. (divisional solicitud 201800458)
ZA201906832B (en) Novel psma-binding agents and uses thereof
MA39095A1 (fr) Anticorps et immunoconjugués anti-cd33
WO2017132580A3 (fr) Intéines clivées à activité d'épissage exceptionnelle
MA43187A (fr) Formulations sous-cutanée d'anticorps anti-cd38 et leurs utilisations
TR201901445T4 (tr) Il2rbeta/yaygın gamma zinciri antikorları.
EP4335874A3 (fr) Anticorps anti-hla-g et leur utilisation
MA39172B1 (fr) Dérivés bicycliques hétérocycliques comme inhibiteurs de bromodomaines
EA201792616A1 (ru) Средства, пути применения и способы лечения синуклеопатии
MX2017016169A (es) Anticuerpos anti-her2 y metodos de uso.
EA201790173A1 (ru) Антитела, связывающие axl
EA202190609A1 (ru) Антитела против hla-g, композиции, содержащие антитела против hla-g, и способы применения антител против hla-g
EA202090296A1 (ru) Спироциклические соединения и способы их получения и применения
WO2017136659A3 (fr) Anticorps humanisés anti-cd3, conjugués et leurs utilisations
PH12019501872A1 (en) Anti-tryptase antibodies, compositions thereof, and uses thereof
EA201591665A1 (ru) Оральные составы деферазирокса
MA47221A1 (fr) Anticorps monoclonal à pd-l1
PH12020550964A1 (en) Heavy chain antibodies binding to cd22
EA202090312A1 (ru) Спироциклические соединения и способы их получения и применения
CL2018000092A1 (es) Anticuerpos que se unen a la sortilina e inhiben la union de progranulina.